Substance P Infusion into Striatum Relieves Neuropathic Pain via Muscarinic Receptor Pathway
Continuous substance P infusion into the rat striatum dose-dependently relieved chronic neuropathic pain through NK1 receptors activating muscarinic cholinergic neurons — a novel pain pathway.
Quick Facts
What This Study Found
Continuous striatal substance P infusion dose-dependently relieved neuropathic pain via NK1 receptors activating muscarinic cholinergic neurons — a novel brain-based analgesic pathway.
Key Numbers
SP dose-dependent at 0.2-0.8 ug/mL; NK1R-dependent (CP96345); muscarinic-dependent (atropine); nicotinic-independent (mecamylamine); acute/ipsilateral ineffective
How They Did This
Animal study using reverse microdialysis to deliver continuous substance P into rat striatum after partial sciatic nerve ligation, with pharmacological dissection using NK1 antagonist, atropine, and mecamylamine.
Why This Research Matters
Neuropathic pain is notoriously difficult to treat. This study identifies a new brain circuit — striatal substance P activating cholinergic neurons — that could be targeted for chronic pain management.
The Bigger Picture
This challenges the conventional view of substance P as purely pro-pain. In the brain's striatum, it acts as an analgesic through a cholinergic pathway, suggesting the neuropeptide has context-dependent roles.
What This Study Doesn't Tell Us
Invasive brain infusion delivery — not clinically practical as-is; rat model; only mechanical hypersensitivity tested; acute injection was ineffective, requiring continuous administration.
Questions This Raises
- ?Could this NK1-muscarinic pathway be targeted with less invasive approaches?
- ?Why does only continuous contralateral infusion produce analgesia?
- ?Do muscarinic agonists alone provide similar neuropathic pain relief?
Trust & Context
- Key Stat:
- Novel NK1→muscarinic pain pathway Substance P relieves neuropathic pain through striatal NK1 receptors activating muscarinic cholinergic neurons
- Evidence Grade:
- Strong mechanistic animal study with dose-response, receptor-specific antagonism, and multiple controls, but limited to invasive delivery and one pain model.
- Study Age:
- Published in 2020; complements parallel study on substance P in inflammatory pain, together mapping striatal neuropeptide analgesia.
- Original Title:
- Continuous infusion of substance P into rat striatum relieves mechanical hypersensitivity caused by a partial sciatic nerve ligation via activation of striatal muscarinic receptors.
- Published In:
- Behavioural brain research, 391, 112714 (2020)
- Authors:
- Nakamura, Yoki(2), Fukushige, Ryo(2), Watanabe, Kohei(2), Kishida, Yuki, Hisaoka-Nakashima, Kazue, Nakata, Yoshihiro, Morioka, Norimitsu
- Database ID:
- RPEP-05023
Evidence Hierarchy
Frequently Asked Questions
Is substance P a pain-causing or pain-relieving peptide?
Both — in peripheral nerves it promotes pain signaling, but when infused into the brain striatum it activates cholinergic pathways that reduce pain, showing context-dependent effects.
What is neuropathic pain?
Pain caused by nerve damage (like sciatic nerve injury), often presenting as heightened sensitivity to touch. It is difficult to treat with standard painkillers and often becomes chronic.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05023APA
Nakamura, Yoki; Fukushige, Ryo; Watanabe, Kohei; Kishida, Yuki; Hisaoka-Nakashima, Kazue; Nakata, Yoshihiro; Morioka, Norimitsu. (2020). Continuous infusion of substance P into rat striatum relieves mechanical hypersensitivity caused by a partial sciatic nerve ligation via activation of striatal muscarinic receptors.. Behavioural brain research, 391, 112714. https://doi.org/10.1016/j.bbr.2020.112714
MLA
Nakamura, Yoki, et al. "Continuous infusion of substance P into rat striatum relieves mechanical hypersensitivity caused by a partial sciatic nerve ligation via activation of striatal muscarinic receptors.." Behavioural brain research, 2020. https://doi.org/10.1016/j.bbr.2020.112714
RethinkPeptides
RethinkPeptides Research Database. "Continuous infusion of substance P into rat striatum relieve..." RPEP-05023. Retrieved from https://rethinkpeptides.com/research/nakamura-2020-continuous-infusion-of-substance-2
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.